HALO logo
halo search icon
Lakefront Biotherapeutics Sponsored ADR
Lakefront Biotherapeutics Sponsored ADR
LKFT · NAS

Lakefront Biotherapeutics Sponsored ADR

US$27.77

Price Arrow0.37 (1.35%)
21/05/2026 04:00:00 PM
All-ConsensusNear 52 Week LowNear Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Lakefront Biotherapeutics Sponsored ADR Overview

LKFT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About LKFT

icon

Telephone

32.1.534.29.00

icon

Address

Generaal de Wittelaan L11 A3, Industriepark Mechelen Noord, Mechelen, Brussels Region 2800

Description

Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

LKFT Price Chart

Key Stats

Market Cap

US$1.80B

PE

6.00

EV/EBITDA

-2.3

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 26.42 - 37.78

Trade Value (12mth)

US$1,527,445.00

1 week

1.29%

1 month

-5.97%

YTD

-16.89%

1 year

-4.8%

All time high

274.03

Key Fundamentals

EPS 3 yr Growth

-257.60%

EBITDA Margin

46.90%

Operating Cashflow

-$222m

Free Cash Flow Return

-6.50%

ROIC

10.60%

Interest Coverage

310.40

Quick Ratio

20.00

Other Data

Shares Outstanding (Fully Diluted)

69m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

LKFT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock3.471.225.5locklocklock
EPS (Fully Diluted)
$locklocklocklock3.471.225.5locklocklock
Growth
%locklocklocklock199.6-65351.9locklocklock
PE
Xlocklocklocklock11.722.66locklocklock
EV/EBITDA
XlocklocklocklockN/AN/A-2.3locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS)?
Halo FAQ
The current share price of Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS) is USD$27.77.
What is the 52-week high share price for Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS)?
Halo FAQ
The 52-week high share price for Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS) is USD$37.78.
What is the 52-week low share price for Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS)?
Halo FAQ
The 52-week low share price for Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS) is USD$26.42.
What is the dividend yield for Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS)?
Halo FAQ
Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS) does not pay a dividend.
What was Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS) last dividend payment?
Halo FAQ
Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS) does not pay a dividend.
What is the franking level for Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS)?
Halo FAQ
Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS) has a franking level of 0.00%.
In which sector is Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS) classified?
Halo FAQ
Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS)?
Halo FAQ
The current P/E ratio for Lakefront Biotherapeutics Sponsored ADR (LKFT:NAS) is 6.00.

See beyond the curve.

One solution for research, investing and portfolio management.